Epigenetic SMAD3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma
Journal: Cancer Research
Published: 2020-01-15
DOI: 10.1158/0008-5472.can-19-0637
Affiliations: 18
Go to article